section name header

Pronunciation

pa-TIR-oh-mer

Classifications

Therapeutic Classification: antidotes, electrolyte modifiers

Pharmacologic Classification: cationic exchange resins

Indications

REMS


Action

  • Contains calcium-sorbitol counterion and fecal potassium excretion through binding of potassium in the lumen of the GI tract.
Therapeutic effects:
  • Reduced serum potassium concentrations.

Pharmacokinetics

Absorption: Not systemically absorbed.

Distribution: Not distributed.

Metabolism/Excretion: Eliminated in the feces.

Half-Life: Unknown.

Time/Action Profile

( in serum potassium concentrations)
ROUTEONSETPEAKDURATION
PO7–12 hrunknown24 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

F and E: hypokalemia, hypomagnesemia

GI: constipation, diarrhea, flatulence, nausea

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Veltassa